scholarly article | Q13442814 |
P2093 | author name string | Shenkman B | |
Savion N | |||
Varon D | |||
Knobler H | |||
Kotev-Emeth S | |||
P2860 | cites work | Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration | Q29619529 |
The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress | Q34182746 | ||
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty | Q34336722 | ||
Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study | Q35009072 | ||
The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty | Q37694282 | ||
Evaluation of the clinical utility of platelet aggregation studies | Q38897612 | ||
Platelet lipoprotein interactions | Q39530368 | ||
Do platelets have anything to do with diabetic microvascular disease? | Q40119288 | ||
Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis | Q40837696 | ||
Potential mechanisms promoting restenosis in diabetic patients | Q40973029 | ||
Platelet hyperreactivity and prognosis in survivors of myocardial infarction | Q41229453 | ||
Thromboxane biosynthesis and platelet function in type I diabetes mellitus | Q41429378 | ||
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial | Q44459441 | ||
A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions | Q45880969 | ||
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. | Q51010819 | ||
Can restenosis after coronary angioplasty be predicted from clinical variables? | Q52228108 | ||
Increased Platelet Aggregation in Early Diabetus Mellitus | Q66941531 | ||
Effects of dietary and pharmacologic alteration of serum lipids on platelet survival time | Q67352454 | ||
The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension | Q67516409 | ||
Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men | Q67730473 | ||
Platelet abnormalities in diabetes mellitus | Q68046313 | ||
Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus | Q70555895 | ||
Platelet function in diabetes mellitus | Q71503473 | ||
Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina | Q71971760 | ||
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy | Q72408304 | ||
Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro | Q72520278 | ||
Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients | Q72727482 | ||
The influence of lipoproteins on blood platelets | Q72940230 | ||
Are we mortgaging the medical profession? | Q95814757 | ||
P433 | issue | 4 | |
P304 | page(s) | 181-190 | |
P577 | publication date | 1998-05-01 | |
P1433 | published in | Thrombosis Research | Q15758741 |
P1476 | title | Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients | |
P478 | volume | 90 |
Q54057930 | Abciximab reduces mortality in diabetics following percutaneous coronary intervention. |
Q44371721 | Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus |
Q28193753 | Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus |
Q26823633 | Assessment of platelet inhibition by point-of-care testing in neuroendovascular procedures |
Q33629000 | Barriers to Implementing an Insulin Order Form In a Non-ICU Medical Unit. |
Q52355379 | Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets. |
Q36567704 | Determination of normal range of bleeding time in rural and urban residents of Borujerd, Iran: A pilot study |
Q37588694 | Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases |
Q37858336 | Endoplasmic-reticulum calcium depletion and disease |
Q35854008 | Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. |
Q55045262 | In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry. |
Q51554134 | Increased plasma endothelin-1 and intraplatelet cyclic guanosine monophosphate in men with disturbed glucose metabolism. |
Q24800363 | Influence of diabetes mellitus on heart failure risk and outcome |
Q50019585 | Long-term Prognosis and Clinical Characteristics of Patients with Newly Diagnosed Diabetes Mellitus Detected after First Acute Myocardial Infarction: from KAMIR-NIH Registry |
Q51243894 | Maternal selective serotonin reuptake inhibitor intake does not seem to affect neonatal platelet function tests. |
Q28196731 | Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects |
Q28193664 | Optimizing the diabetic formulary: beyond aspirin and insulin |
Q36320564 | Pathobiology and cell interactions of platelets in diabetes |
Q35813673 | Percutaneous coronary intervention in diabetics |
Q28186087 | Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense |
Q36052944 | Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes |
Q24793107 | Risk factors in coronary atherosclerosis athero-inflammation: the meeting point |
Q46313799 | Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)]. |
Q74238336 | Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor |
Q35584004 | The Role of Glycoprotein IIb/IIIa-Receptor Antagonists in Diabetics |
Q37798968 | The role of calpain in diabetes-associated platelet hyperactivation. |
Q33870602 | The role of plaque rupture and thrombosis in coronary artery disease |
Q33998463 | The role of platelets in diabetes-related vascular complications |